• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Lee Schwartzberg on the Exclusion of Men From BRCA Screening Recommendations

Video

Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, discusses exclusion of men from the US Preventive Services Task Force's (USPSTF's) updated BRCA screening recommendation update.

Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, discusses exclusion of men from the US Preventive Services Task Force's (USPSTF's) updated BRCA screening recommendation update.

Transcript

What are your thoughts on USPSTF leaving men out of its updated recommendation for BRCA1/2 screening and testing?

Well, I believe that all men who have breast cancer, for example, should be tested. About 10% of them will have a hereditary, usually a BRCA 1 or 2 gene. The number of genes that contribute to hereditary breast or ovarian cancer is broadening over time, and so we’re learning more over time as we move from the very high penetrant cancer syndromes to somewhat less, but we’re learning a lot, so I think men will be included in the near future.

Related Videos
Pat Van Burkleo
Jeff Stark, MD, vice president, head of medical immunology, UCB
Robert Groves, MD
Screenshot of Raajit Rampal, MD, PhD
 Laura Ferris, MD, PhD, professor of dermatology, University of Pittsburgh
Dr Padma Sripada, Columbia Internal Medicine
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
dr amy paller
Shawn Kwatra, MD, dermatologist, John Hopkins University
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.